Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,584 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02467647 | The Effects of Huang-Lian-Jie-Du-Tang(HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy(HLJDT-2016) | unknown | Phase 1 | 500 | Wuhan UniversityOTHER | 1 | Jun 10, 2015 | clinicaltrials |
| NCT01919710 | Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia | completed | Phase 1 | 29 | Tianjin SinoBiotech Ltd.INDUSTRY | 1 | Jun 3, 2015 |
| NCT02074046 | Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02084823 | Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02089919 | Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02278458 | Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer | unknown | Phase 1 | 24 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT01110941 | Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China(SCI-101) | completed | Phase 1 / Phase 2 | 20 | Shen LinOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 19 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01795716 | Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body | completed | Phase 1 | 21 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | May 19, 2015 | clinicaltrials |
| NCT01584544 | Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer | completed | Phase 1 | 24 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 20, 2015 | clinicaltrials |
| NCT01914263 | Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection | unknown | Phase 1 | 40 | Alliancells-PuRui Biocience Co., Ltd.INDUSTRY | 1 | Apr 16, 2015 | clinicaltrials |
| NCT01772732 | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC | unknown | Phase 1 | 30 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 9, 2015 | clinicaltrials |
| NCT01268943 | Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients | completed | Phase 1 | 18 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 6, 2015 | clinicaltrials |
| NCT01847118 | A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 31 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02066870 | Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI | unknown | Phase 1 | 9 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT02378389 | Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer | unknown | Phase 1 | 28 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 4, 2015 | clinicaltrials |
| NCT01930552 | A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies | completed | Phase 1 | 20 | SanofiINDUSTRY | 1 | Jan 7, 2015 | clinicaltrials |
| NCT02331693 | CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR | unknown | Phase 1 | 10 | RenJi HospitalOTHER | 1 | Jan 6, 2015 | clinicaltrials |
| NCT01324492 | Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor(\MACS1304) | completed | Phase 1 | 16 | Novartis PharmaceuticalsINDUSTRY | 1 | Dec 30, 2014 | clinicaltrials |
| NCT02314884 | Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours | unknown | Phase 1 | 40 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 12, 2014 | clinicaltrials |
| NCT02277158 | Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer. | unknown | Phase 1 | 18 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01462903 | A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT02274584 | CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) | unknown | Phase 1 / Phase 2 | 20 | Peking UniversityOTHER | 2 | Oct 24, 2014 | clinicaltrials |
| NCT02247609 | Evaluation of 4th Generation Safety-designed CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas(4SCAR19273) | unknown | Phase 1 / Phase 2 | 20 | Peking UniversityOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT01611961 | Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients | unknown | Phase 1 | 35 | Shenyang Pharmaceutical UniversityOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT01824524 | A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer | completed | Phase 1 | 12 | Xian-Janssen Pharmaceutical Ltd.INDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT01540461 | Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC) | completed | Phase 1 | 17 | Bristol-Myers SquibbINDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT02178280 | Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT02169388 | Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy | unknown | Phase 1 | 30 | Shandong UniversityOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT02166554 | The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions(BAP) | completed | Phase 1 / Phase 2 | 216 | BioRegen Biomedical (Changzhou) Co., LtdINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT02140606 | Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) | unknown | Phase 1 | — | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT02131688 | Phase I Study of Mitoxantrone Hydrochloride Liposome Injection | unknown | Phase 1 | 30 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | May 6, 2014 | clinicaltrials |
| NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | completed | Phase 1 / Phase 2 | 86 | Chinese PLA General HospitalOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01712919 | Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) | completed | Phase 1 / Phase 2 | 61 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Mar 24, 2014 | clinicaltrials |
| NCT02081937 | CART-19 Immunotherapy in Mantle Cell Lymphoma | unknown | Phase 1 / Phase 2 | 2 | Chinese PLA General HospitalOTHER | 1 | Mar 11, 2014 | clinicaltrials |
| NCT01516983 | Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation | completed | Phase 1 / Phase 2 | 15 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT01735409 | Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma(ABX-DDP-Dose) | unknown | Phase 1 / Phase 2 | 69 | Sun Yat-sen UniversityOTHER | 1 | Jan 28, 2014 | clinicaltrials |
| NCT01993784 | Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. | unknown | Phase 1 / Phase 2 | 9 | Peking UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01846650 | A Bioequivalence Study of Capecitabine Tablets | completed | Phase 1 | 36 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Oct 1, 2013 | clinicaltrials |
| NCT01291407 | A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer | completed | Phase 1 | 27 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 18, 2013 | clinicaltrials |
| NCT01931943 | A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer | unknown | Phase 1 | 24 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 30, 2013 | clinicaltrials |
| NCT01930630 | ESI With EUS to Differentiate T3 and T4 ESCC(ESI) | unknown | Phase 1 | 10 | Sun Yat-sen UniversityOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | unknown | Phase 1 / Phase 2 | 40 | Fudan UniversityOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT01806376 | A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics | unknown | Phase 1 | 20 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Mar 8, 2013 | clinicaltrials |
| NCT01238562 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients(Filgrastim) | completed | Phase 1 | 30 | Xiamen Amoytop Biotech Co., Ltd.INDUSTRY | 1 | Feb 4, 2013 | clinicaltrials |
| NCT01531790 | A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients | completed | Phase 1 | 19 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01301911 | Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer | terminated | Phase 1 | 26 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT01416623 | A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies | terminated | Phase 1 | 44 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT01213030 | Clinical Evaluation of the New Hypoxia Imaging Agent HX4 | completed | Phase 1 / Phase 2 | 12 | Siemens Molecular ImagingINDUSTRY | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00093444 | Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 2 | Mar 15, 2012 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials